Cargando…
MiR-195 suppresses the metastasis and epithelial–mesenchymal transition of hepatocellular carcinoma by inhibiting YAP
MiR-195, a novel cancer-related microRNA, was previously reported to play an important role in many malignancies. This study aimed to investigate the role of miR-195 mediated epithelial–mesenchymal transition (EMT) and the progression of hepatocellular carcinoma (HCC) as well as the underlying mecha...
Autores principales: | Yu, Shuo, Jing, Li, Yin, Xiao-Ran, Wang, Min-Cong, Chen, Yi-Meng, Guo, Ya, Nan, Ke-Jun, Han, Li-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725129/ https://www.ncbi.nlm.nih.gov/pubmed/29245938 http://dx.doi.org/10.18632/oncotarget.20909 |
Ejemplares similares
-
Regorafenib inhibits epithelial-mesenchymal transition and suppresses cholangiocarcinoma metastasis via YAP1-AREG axis
por: Chang, Yu-Chan, et al.
Publicado: (2022) -
MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets
por: Chen, Shu-peng, et al.
Publicado: (2015) -
Programmed cell death 10 promotes metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma via PP2Ac-mediated YAP activation
por: Sun, Bo, et al.
Publicado: (2021) -
miR-338-3p inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cells
por: Chen, Jing-Song, et al.
Publicado: (2016) -
Deubiquitinating enzyme USP10 promotes osteosarcoma metastasis and epithelial–mesenchymal transition by stabilizing YAP1
por: Deng, Jianyong, et al.
Publicado: (2023)